← back to search

Charlotte Edenius

Karolinska Institutet · SE
Area of research
Physiology · Pharmacology
Research interest
Research interests include Asthma and respiratory diseases, Nitric Oxide and Endothelin Effects, Inflammatory mediators and NSAID effects, and Mast cells and histamine.
h-index
20
citations
1,300
works
50
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's
Lara D. Veeken 2024cited by 13position: middledoi
Selective Cathepsin S Inhibition with MIV-247 Attenuates Mechanical Allodynia and Enhances the Antiallodynic Effects of Gabapentin and Pregabalin in a Mouse Model of Neuropathic Pain
Journal of Pharmacology and Experimental Therapeutics 2016cited by 39position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jan Kowalski · Statistics Sweden1 papers (2024–2024)Biljana Rizoska · BioArctic Neuroscience (Sweden)1 papers (2016–2016)Björn Classon · Medivir (Sweden)1 papers (2016–2016)Ariane L. Herrick · Manchester Academic Health Science Centre1 papers (2024–2024)— · 1 papers (2024–2024)Karin Tunblad · Medivir (Sweden)1 papers (2016–2016)Francesco Del Galdo · University of Leeds1 papers (2024–2024)Urszula Grabowska · F-star (United Kingdom)1 papers (2016–2016)Ian Henderson · Bioscience Research1 papers (2016–2016)Marzia Malcangio · King's College - North Carolina1 papers (2016–2016)Göran Tornling · Karolinska Institutet1 papers (2024–2024)— · 1 papers (2024–2024)Mariusz Korkosz · Shanxi Medical University1 papers (2024–2024)Marina Anderson · University of Liverpool1 papers (2024–2024)John D Pauling · University of Bristol1 papers (2024–2024)— · 1 papers (2024–2024)Erik Lindström · University of Minnesota1 papers (2016–2016)Christopher P. Denton · University of Leeds1 papers (2024–2024)B.-L. Sahlberg · King's College London1 papers (2016–2016)Frances Hall · Cambridge University Hospitals NHS Foundation Trust1 papers (2024–2024)